Evaluation of the effect of reduced-dose pneumococcal conjugate vaccine schedules on vaccine serotype carriage in children and their caretakers in a naïve population in Vietnam: Protocol for a cluster randomized non-inferiority trial [version 1; peer review: 2 approved, 1 approved with reservations]
Introduction: The WHO currently recommends giving pneumococcal conjugate vaccines (PCVs) as three doses – either three doses in infancy with Pentavalent vaccine (3p+0), or two doses in infancy followed by a booster around 12 months (2p+1). However, their high price is a barrier to introduction and s...
Main Authors: | Lay-Myint Yoshida, Kim Mulholland, Stefan Flasche, Cattram Nguyen, Hien-Anh Nguyen, Duc-Anh Dang, Michiko Toizumi |
---|---|
Format: | Article |
Language: | English |
Published: |
F1000 Research Ltd
2023-07-01
|
Series: | Gates Open Research |
Subjects: | |
Online Access: | https://gatesopenresearch.org/articles/7-110/v1 |
Similar Items
-
Rationale and methods of a randomized controlled trial of immunogenicity, safety and impact on carriage of pneumococcal conjugate and polysaccharide vaccines in infants in Papua New Guinea
by: Deborah Lehmann, et al.
Published: (2017-12-01) -
Health and economic outcomes of 20-valent pneumococcal conjugate vaccine compared to 15-valent pneumococcal conjugate vaccine strategies for adults in Greece
by: George Gourzoulidis, et al.
Published: (2023-09-01) -
Invasive pneumococcal disease in persons with predisposing factors is dominated by non-vaccine serotypes in Southwest Sweden
by: Karin Bergman, et al.
Published: (2021-08-01) -
Assessing Public Health Impact of Four Pediatric Pneumococcal Conjugate Vaccination Strategies in the Netherlands
by: Michele Wilson, et al.
Published: (2023-06-01) -
Pneumococcal vaccine uptake and vaccine effectiveness in older adults with invasive pneumococcal disease in Germany: A retrospective cohort study
by: Stephanie Perniciaro, et al.
Published: (2021-08-01)